Menu Back toSession-5-Digital-Innovation-and-e-Tools-Opportunities-and-Challenges

Better Medicines for Children, A DIA/EFGCP Conference

Plan ahead and join us to reflect on the importance of two major headways that are currently affecting Paediatric research: Innovative approaches to Drug Development and impact of the current environment on the Regulatory and Research Infrastructure


Session 5: Digital Innovation and e-Tools – Opportunities and Challenges

Session Chair(s)

Cécile  Ollivier, MS

Cécile Ollivier, MS

  • Chief Innovation and Regulatory Science Officer
  • Aparito , Netherlands
Session 5: Digital Innovation and e-Tools – Opportunities and Challenges

Speaker(s)

Alex  Johnson

Bring the Patient Experience with the Application

Alex Johnson

  • Co-founder and Joint CEO
  • Duchenne UK, United Kingdom
Ralph  Bax, MD, PhD

Ralph Bax, MD, PhD

  • Head of the Paediatric Medicines Office
  • European Medicines Agency, Netherlands
Damien  Eggenspieler

EMA Qualification Procedure: Experience from a Medtech Company

Damien Eggenspieler

  • Healthcare Program Director
  • SYSNAV, France
Aude  Clement

Digital Tools and Drug Development: an Industry Perspective

Aude Clement

  • F. Hoffmann-La Roche AG, Switzerland
Invited  Speaker

Digital Tools and Drug Development: an Industry Perspective

Invited Speaker

  • DIA, Switzerland

Contact us


Registration Questions?

Send Email
+41 61 225 51 51